Other OTC - Delayed Quote USD

PURE Bioscience, Inc. (PURE)

0.0710 +0.0010 (+1.43%)
At close: April 26 at 12:24 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Robert F. Bartlett President, CEO & Director 129.8k -- 1945
Mr. Mark Stuart Elliott VP of Finance and Principal Financial & Accounting Officer 180k -- 1975
Mr. Thomas Richard Myers Executive VP of Technology & Development and Director 200k -- 1953
Mr. Jeff Kitchell VP of Operations & Corporate Secretary -- -- --
Mr. Tim Steffensmeier Vice President of Sales & Marketing -- -- --

PURE Bioscience, Inc.

9669 Hermosa Avenue
Rancho Cucamonga, CA 91730
United States
619 596 8600 https://www.purebio.com
Full Time Employees: 
11

Description

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

Corporate Governance

PURE Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jun 12, 2024 - Jun 17, 2024
PURE Bioscience, Inc. Earnings Call

Related Tickers

REAL.BR Realco SA
14.20
0.00%
 
BYOT.L Byotrol plc
0.1250
0.00%
 
HNST The Honest Company, Inc.
3.1600
+3.61%
 
KMB Kimberly-Clark Corporation
135.24
-0.87%
 
PG The Procter & Gamble Company
161.29
-0.78%